NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional)[E8]

I dettagli del bando sono mostrati come li ha pubblicati la fonte. I fatti e i requisiti che estraiamo sono scritti in inglese.

• Aperto aSmall and medium firms, Startups. Etichettato da SLETOR in base alle parole del bando.

• RischioThis is a grant, not a contract. Grants usually need a proposal against the funder's criteria, may need partners and often need co-funding.[E5]
• SconosciutoThe listing does not say how much funding is available.
• SconosciutoWe read the funder's listing, not the full guidance or application forms.

1. Visto per la prima volta · 28 ott 2026, 21:22 UTC

   The funder published the call with a future closing date.

   Record di origine: NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough… (ID 359758)

Ogni dato di questa pagina viene dal bando dell'ente. Ogni voce mostra il record e il campo da cui è stato letto.

1. E1

   Assistance listing (CFDA) 93.853, 93.838, 93.839, 93.866, 93.307, 93.847, 93.394, 93.837, 93.855, 93.313, 93.393, 93.865, 93.350, 93.242, 93.867, 93.233, 93.351, 93.840, 93.859, 93.273, 93.395.

   Da NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough… (ID 359758), campo /cfdaList, letto 29 ott 2026, 03:42 UTC · fonte ↗ (si apre in una nuova scheda)

2. E2

   The funder is National Institutes of Health.

   Da NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough… (ID 359758), campo /agency, letto 29 ott 2026, 03:42 UTC · fonte ↗ (si apre in una nuova scheda)

3. E3

   The funder is a US federal agency.

   Da NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough… (ID 359758), campo /agencyCode, letto 29 ott 2026, 03:42 UTC · fonte ↗ (si apre in una nuova scheda)

4. E4

   Applications close (11:59 pm Eastern on the close date, the Grants.gov default) on 5 Apr 2029, 23:59 Eastern time (UTC−4).

   “04/05/2029”

   Da NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough… (ID 359758), campo /closeDate, letto 29 ott 2026, 03:42 UTC · fonte ↗ (si apre in una nuova scheda)

5. E5

   This is a posted grant: applications are open.

   Da NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough… (ID 359758), campo /oppStatus, letto 29 ott 2026, 03:42 UTC · fonte ↗ (si apre in una nuova scheda)

6. E6

   The notice was published on 28 May 2026.

   “2026-05-28”

   Da NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough… (ID 359758), campo /openDate, letto 29 ott 2026, 03:42 UTC · fonte ↗ (si apre in una nuova scheda)

7. E7

   Grants.gov gives the status as posted.

   Da NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough… (ID 359758), campo /oppStatus, letto 29 ott 2026, 03:42 UTC · fonte ↗ (si apre in una nuova scheda)

8. E8

   The notice is titled "NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional)".

   Da NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough… (ID 359758), campo /title, letto 29 ott 2026, 03:42 UTC · fonte ↗ (si apre in una nuova scheda)

This product uses the Grants.gov API but is not endorsed or certified by the U.S. Department of Health and Human Services. Licenza dei dati: Grants.gov API terms of use ↗ (si apre in una nuova scheda). I recapiti personali presenti nei bandi non vengono conservati né mostrati.